Site icon Market Globalist

Did Anything Boost Syros Pharmaceuticals (SYRS) Stock Pre-Hours Trading?

SYRS Stock

SYRS Stock

The share price of Syros Pharmaceuticals Inc. (NASDAQ: SYRS) rose 7.90% in pre-market trading hours to $ 0.7870 on the last check Friday after progress was made toward a merger agreement. At the end of the last trading session, SYRS’ stock gained 3.02% to $0.73, trading in a range of $0.683 to $0.75.

Is the merger deal going well for SYRS?

The results of the special meetings of Syros Pharmaceuticals (SYRS) and Tyme Technologies, Inc. (TYME) held on September 15, 2022, have been announced.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


How will SYRS deal with it?

Syros Pharmaceuticals (SYRS) expects the Merger and PIPE financing to close on or about Friday, September 16, 2022. In the aftermath of the merger, Syros’ existing management team, including Nancy Simonian, M.D., Chief Executive Officer of Syros, will lead the combined company that will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS” and continue to focus on the development of SYRS’ pipeline of small molecule cancer medicines.

Exit mobile version